Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002390

Principal Accounting Officer sold 1,039 shares at $15.17 ($15,762)

From the SEC's structured data for this filing

Trades in this filing

Dunn Edmund · Principal Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-05 Sale : show line 1 in the form −1,039 $15.17 $15,762 22,693 D
Open-market sales · 1,039 sh · avg $15.17 · $15,762
Loading xslF345X05/ownership.xml…